Clinical Trial: Pulmonary Arterial Hypertension and Associated Cardiovascular Disease Detection Using Artificial Intelligence

U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147725) titled 'Pulmonary Arterial Hypertension and Associated Cardiovascular Disease Detection Using Artificial Intelligence' on Aug. 22.

Brief Summary: Cardiovascular disease (CVD) is a leading global cause of morbidity and mortality and excessive healthcare expenditures. Pulmonary hypertension (PH) represents an insidious and progressive subset of CVD affecting an estimated 1% of the general population, increasing to up to 10% in the population over the age of 65. Recent advancements in artificial intelligence (AI) have shown promise in transforming PH diagnosis by enabling the analysis of complex physiological data. Specifically, AI algorithms ...